Welcome to Tech Beat, your daily read on what matters in technology.
Drug discovery has long been one of the most expensive bets in science, and the numbers are staggering. Bringing a single drug to market now takes between ten and fifteen years and costs upward of one to two and a half billion dollars. Researchers are increasingly turning to AI to close that loop, using machine learning to compress timelines and cut the dead ends that drive so much of that cost.
On the enterprise side, the conversation around AI is shifting from chatbots to something with far more operational weight. Agentic AI systems are being designed to execute full business workflows end-to-end, touching people, data, and systems autonomously. The infrastructure required to do that reliably, with proper memory, observability, and policy controls, is becoming its own competitive frontier.
And in crypto markets, Bitcoin ETFs snapped a seven-day inflow streak in a sharp reversal. Outflows hit four hundred sixty-five million dollars over just two days, with BlackRock's IBIT product accounting for the bulk of the selling. Analysts are pointing to renewed tensions between the United States and Iran, along with fears of Federal Reserve rate hikes, as the likely triggers.
That's your briefing for today. Keep surfing. Tech Beat out.
